Hpgc Renmintongtai Pharmaceutical Corporation Class ASSE: 600829

Semi-annual Report in 2024

Aug 9, 2024 · Issued by Hpgc Renmintongtai Pharmaceutical Corporation Class A via Shanghai Stock Exchange

Semi-annual Report in 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment